Information about Xpharma
My details
*
*
*

Xpharma (SRL)

BE 0663.736.158

Zavelstraat 14, 2870 Puurs-Sint-Amands

Company information

Status
Active

Enterprise number

BE0663.736.158

VAT liability
Yes
Established
03-10-2016
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Xpharma

2024 2023 2022 2021
Profit/Loss € 316,547 55 % € 204,764 0 % € 203,938 169 % € 75,772
Equity € 631,006 101 % € 314,459 -13 % € 359,695 151 % € 143,357
Gross margin € 148,899 14 % € 130,973 51 % € 86,518 -55 % € 193,344

Publications from Xpharma

Date Publication
22-09-2023 Registered Office (NL)
28-09-2022 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Goal - Resignations - Appointments (NL)
05-10-2016 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Xpharma?
The VAT number of Xpharma is BE 0663.736.158.
Wat is the PEPPOL ID of Xpharma?
The PEPPOL ID of Xpharma is 0208:0663736158. Log in or start a free trial to see the full overview.
When was Xpharma founded?
Xpharma was founded on 03-10-2016.
What is the address of Xpharma?
The current registered office of Xpharma is located at Zavelstraat 14, 2870 Puurs-Sint-Amands.
When was the last time Xpharma filed their annual financial statements?
The most recent financial statements of Xpharma were filed on 02-04-2025.
How many employees does Xpharma have?
There are currently no employees working at Xpharma or no workforce information is available.
What is the annual turnover of Xpharma?
At the time of its most recent financial statements, Xpharma did not publish any turnover figures. Xpharma reported a gross margin of €148,899.33.

Sources